Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Fenretinide

EU orphan designation number: EU/3/06/427
Active ingredient: Fenretinide
Indication: Treatment of soft tissue sarcoma
Sponsor: Cancer Research UK
Angel Building, 407 St John Street, London EC1V4AD, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/02/2007 Centralised Orphan - Designation EMEA/OD/083/06 (2007)362 of 30/01/2007
23/02/2011 Centralised Orphan - Removal of orphan designation from Community Register
01/03/2011 Other procedure EMEA/OD/083/06